Specifically, our findings are particularly relevant to breast cancer, hepatocellular carcinoma (HCC), and oral squamous cell carcinoma (OSCC), where the miR-21/PTEN axis plays a critical role in modulating cellular behaviors. This evidence concerns the gene PTEN and breast cancer.